Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences
ES-miRNA 和环境风险因素之间的相互作用导致 TNBC 进展和相关种族健康差异:一项采用多级调节推论的新颖分析
基本信息
- 批准号:10594746
- 负责人:
- 金额:$ 33.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary:
For women in the United States, breast cancer is not only the most common malignancy but also the second
leading cause of death. In this application, we focus on a specific subtype of breast cancer known as triple-
negative breast cancer (TNBC). Because TNBC has a higher recurrence rate and poorer overall mortality than
other subtypes of breast cancer, it is more aggressive and extremely difficult to treat with standard therapies.
Epidemiological studies have clearly shown that African American (AA) women are more likely to develop
advanced TNBC than Caucasian American (CA) women. For instance, in Louisiana (LA), where we live, from
2010 to 2017, there were 3,790 TNBC cases, of which 1,861 (49.1%) were from the AA population versus 1,900
(50.1%) were from the CA population, while 32.8% of the LA population were AA and 62.8% were CA. Notably,
43.5% of the AA patients were diagnosed with regional or distant metastasis, compared with 36.6% of CA
patients. Thus, TNBC represents a significant challenge to racial health disparities in Louisiana. The overall goal
of this project is to determine the extent to which modifiable factors in the neighborhood physical and social
environment affect the prognosis of TNBC patients and whether their effects can be accurately reflected and
quantified through detectable biological variables. Recent studies have revealed that tumor-derived exosomes
(TDEs) play a prominent role in promoting tumor progression and metastasis. TDEs contain many oncogenic
elements, including multiple miRNAs, mRNAs, proteins, and lipids. Notably, exosomal miRNAs (ES-miRs) have
been reported to be critical for crosstalk between tumor cells and stromal cells in the tumor microenvironment
(TME) and the establishment of pre-metastatic niches. Therefore, we hypothesize that ES-miRs are biological
variables that not only reflect and quantify the effects of environmental risk factors associated with racial
health disparities, but are also functionally involved in the progression of TNBC. Our specific aims are as
follows: Aim 1: Use multilevel mediation and moderation analysis to identify significant ES-miRs and
environmental risk factors for TNBC progression and understand how their interactions explain racial health
disparities in TNBC. Aim 2: Validate the function of selected ES-miRs in TNBC progression using in vitro and in
vivo models. Aim 3: Develop a new model to predict TNBC progression in AA and CA patients. We expect that
our study can develop an innovative approach to quantify adverse physical and social environmental influences
on the progression of TNBC across different races and provide insights into the development of more effective
strategies to reduce racial health disparities in TNBC.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Yaguang Xi的其他基金
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
开发 LG007 作为治疗三阴性乳腺癌的新型治疗剂
- 批准号:1088941110889411
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
舒林酸使结直肠癌对抗 PD-L1 疗法敏感
- 批准号:1088941210889412
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
MiR-17 mediates sulindac anti-metastatic activity in human colorectal cancer
MiR-17 介导舒林酸在人结直肠癌中的抗转移活性
- 批准号:1025811910258119
- 财政年份:2022
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
舒林酸使结直肠癌对抗 PD-L1 疗法敏感
- 批准号:1053882310538823
- 财政年份:2022
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Investigate interactive roles of environmental, behavioral and genetic factors on racial disparities in breast cancer outcomes
研究环境、行为和遗传因素对乳腺癌结果种族差异的交互作用
- 批准号:1065504910655049
- 财政年份:2021
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
开发 LG007 作为治疗三阴性乳腺癌的新型治疗剂
- 批准号:1031312810313128
- 财政年份:2021
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer
开发 LG007 作为治疗三阴性乳腺癌的新型治疗剂
- 批准号:1047744410477444
- 财政年份:2021
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
MicroRNA and colorectal cancer chemoprevention
MicroRNA 与结直肠癌化学预防
- 批准号:93253029325302
- 财政年份:2015
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
MicroRNA and colorectal cancer chemoprevention
MicroRNA 与结直肠癌化学预防
- 批准号:93136039313603
- 财政年份:2015
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression
MicroRNA,NSAID 舒林酸预防结肠癌进展的新成员
- 批准号:87077358707735
- 财政年份:2014
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:1082220210822202
- 财政年份:2024
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:1067878910678789
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:1067704710677047
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:1070212610702126
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:1070130910701309
- 财政年份:2023
- 资助金额:$ 33.63万$ 33.63万
- 项目类别: